Cardiac changes in Parkinson's disease: lessons from clinical and experimental evidence

L Cuenca-Bermejo, P Almela… - International Journal of …, 2021 - mdpi.com
Dysautonomia is a common non-motor symptom in Parkinson's disease (PD). Most
dysautonomic symptoms appear due to alterations in the peripheral nerves of the autonomic …

Nitric oxide involvement in cardiovascular dysfunctions of Parkinson disease

MC Martins-Pinge, L de Jager… - Frontiers in …, 2022 - frontiersin.org
Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the
substantia nigra, causing motor changes. In addition to motor symptoms, non-motor …

Propolis as a potential disease-modifying strategy in Parkinson's disease: cardioprotective and neuroprotective effects in the 6-OHDA rat model

V C. Gonçalves, D JLL Pinheiro, T de la Rosa… - Nutrients, 2020 - mdpi.com
Patients with Parkinson's disease (PD) manifest nonmotor and motor symptoms. Autonomic
cardiovascular dysregulation is a common nonmotor manifestation associated with …

Effects of preventive treadmill exercise on the recovery of metabolic and mitochondrial factors in the 6-hydroxydopamine rat model of Parkinson's disease

Z Rezaee, SM Marandi, H Alaei, F Esfarjani… - Neurotoxicity …, 2019 - Springer
Metabolic and mitochondrial dysfunction has been implicated in Parkinson's disease, while
exercise can induce essential pathways of mitochondrial biogenesis. Here, we tested …

Cardiovascular evaluation of female rats with 6-OHDA-induced parkinsonism: Possible protection by ovarian hormones and participation of nitric oxide

BH de Campos, L de Jager, GS Reginato… - Life sciences, 2020 - Elsevier
Aims Parkinson's disease (PD) is a neurological disorder caused by environmental and
genetic factors, characterized by the death of dopaminergic neurons of the substantia nigra …

Role of the iNOS isoform in the cardiovascular dysfunctions of male rats with 6-OHDA-induced Parkinsonism

L de Jager, CB Vidigal, BH de Campos, GS Reginato… - Nitric Oxide, 2023 - Elsevier
Introduction Available studies have shown the involvement of nitric oxide (NO) in the
processes that lead to neurodegeneration in Parkinson's disease (PD). Also, the use of …

[HTML][HTML] Angiotensin II, dopamine and nitric oxide. An asymmetrical neurovisceral interaction between brain and plasma to regulate blood pressure

I Banegas, I Prieto, AB Segarra… - AIMS …, 2019 - ncbi.nlm.nih.gov
Vital functions, such as blood pressure, are regulated within a framework of neurovisceral
integration in which various factors are involved under normal conditions maintaining a …

[PDF][PDF] The metabolically effects of the short term endurance training among rat model of 6-hydroxydopamine Parkinson's disease

SM Marandi, H Alaei… - Medical Journal of …, 2020 - library.go4manusub.com
Background: Parkinson's disease (PD) is known to affects the Body weight. These changes
are due to multifactorial different mechanisms and training can affect on these disorders. In …

[图书][B] Strategies and Mechanisms to Reduce Locomotor Impairment in Aging and Parkinson's Disease

EA Kasanga - 2021 - search.proquest.com
The maintenance of physical function throughout the lifespan is a hallmark of successful
aging. However, vulnerability to motor impairment during aging is evident in a substantial …

[PDF][PDF] Вплив пропаргілгліцину на ендотелійзалежне розслаблення судин і утворення супероксидного аніона при старінні

KО Драчук, НО Дорофеєва, ВФ Сагач - … Journal/Fiziologichnyi Zhurnal, 2020 - fz.kiev.ua
Вивчали вплив інгібітора цистатіонін-ɣ-ліазазалежного шляху синтезу сірководню
(H2S), пропаргілгліцину на ендотелійзалежне розслаблення судин та активність …